首页/数据集/Gemigliptin ameliorates left ventricular dysfunction in diabetes.

Gemigliptin ameliorates left ventricular dysfunction in diabetes.

NIAID Data Ecosystem2026-03-09 收录

数据链接：

https://figshare.com/articles/dataset/Gemigliptin_ameliorates_left_ventricular_dysfunction_in_diabetes_/3108865 数据链接链接失效反馈

官方服务：

资源简介：

Gemigliptin ameliorates left ventricular dysfunction in diabetes.

应用场景：

创建时间：

2016-03-11

药物疗效评估

免疫反应

Supplementary Information to accompany and support the manuscript: Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults

Mendeley Data2024-03-27 更新210

DOM FIGURE S1 Supplementary data for studies in Figure 3.

药物疗效评估

代谢疾病模型

A,B. Body weights of the 1-wk study (Fig. 3A-D). C. Body weights for the 4-week and 8-week study (Fig. 3E-L). D. Liver gene expression of 1-wk treatment with PF-04991532. E-G. Plasma insulin of drug t

DataCite Commons2020-06-25 更新70

Changes in body weight in the different groups (*p < 0.05).

体重变化监测

药物疗效评估

D0: start of the treatment. D7: 8th day of treatment. D15: 16th day of treatment. D21: 22h day of treatment. D29: 30th day of treatment. Changes in body weight in the different groups (*p < 0.05).

NIAID Data Ecosystem30

Expression data from mouse aorta during and following transient hyperglycaemia. Mus musculus

糖尿病心血管并发症

主动脉基因表达谱

Immediate and early effects of transient hyperglycaemia were examined using fully- reversible transgenic diabetic mice. Transient hyperglycaemia altered expression of 769 arterial genes, of which 200

NIAID Data Ecosystem90

Second-line treatment of metastatic colorectal cancer with HR070803 in combination with 5-FU/LV and BP102

肿瘤临床试验

药物疗效评估

Interventions: experimental group:HR0708035, FU/LV and BP102 Primary outcome(s): Objective response rate Study Design: Single arm

NIAID Data Ecosystem40